AR

Arontier

Seoul, KR · 2 known investors

arontier.co ↗

Arontier uses AI and language models to design antibody therapeutics, focusing on generative methods for CDR backbone design, deimmunization, and epitope-specific antibody classification. The company serves the therapeutic development industry.

Investors · 2

KI

Kiwoom InvestmentSeoul

WE

We VenturesSeoul · $743K – $19M